tirzepatide cardiovascular outcomes trial 2024 linked to lower risk for death, adverse CV and kidney vs. GLP-1s Bridging the gap between GLP1-receptor

If you need a prescription you must go to your medical provider or we can contact them on your behalf to obtain a valid prescription

800-619-6337 Tirzepatide is a cutting-edge, once-weekly injectable prescription medication meticulously engineered to address the challenges of type 2 diabetes and obesity

Patients should inform their pharmacist or physician about all medications they are currently taking, including: Discussing current medications, such as metformin , liraglutide , or any herbal products , with a healthcare provider is essential to avoid potential interactions

Week 1: 5 mg = 0.50 mL (50 units)

Patients considering a change should discuss these benefits with their healthcare provider